These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
273 related articles for article (PubMed ID: 18805456)
1. Applicability, reliability, sensitivity, and specificity of six Brighton Collaboration standardized case definitions for adverse events following immunization. Kohl KS; Magnus M; Ball R; Halsey N; Shadomy S; Farley TA Vaccine; 2008 Nov; 26(50):6349-60. PubMed ID: 18805456 [TBL] [Abstract][Full Text] [Related]
2. Can the Brighton Collaboration case definitions be used to improve the quality of Adverse Event Following Immunization (AEFI) reporting? Anaphylaxis as a case study. Gold MS; Gidudu J; Erlewyn-Lajeunesse M; Law B; Vaccine; 2010 Jun; 28(28):4487-98. PubMed ID: 20434547 [TBL] [Abstract][Full Text] [Related]
3. Vaccinovigilance in Europe--need for timeliness, standardization and resources. Lankinen KS; Pastila S; Kilpi T; Nohynek H; Mäkelä PH; Olin P Bull World Health Organ; 2004 Nov; 82(11):828-35. PubMed ID: 15640918 [TBL] [Abstract][Full Text] [Related]
4. The development of standardized case definitions and guidelines for adverse events following immunization. Kohl KS; Gidudu J; Bonhoeffer J; Braun MM; Buettcher M; Chen RT; Drammeh B; Duclos P; Heijbel H; Heininger U; Hummelman E; Jefferson T; Keller-Stanislawski B; Loupi E; Marcy SM Vaccine; 2007 Aug; 25(31):5671-4. PubMed ID: 17400339 [No Abstract] [Full Text] [Related]
5. The Brighton Collaboration: addressing the need for standardized case definitions of adverse events following immunization (AEFI). Bonhoeffer J; Kohl K; Chen R; Duclos P; Heijbel H; Heininger U; Jefferson T; Loupi E Vaccine; 2002 Dec; 21(3-4):298-302. PubMed ID: 12450705 [TBL] [Abstract][Full Text] [Related]
6. Applicability of the Brighton Collaboration Case Definition for seizure after immunization in active and passive surveillance in Canada. Top KA; Constantinescu CM; Laflèche J; Bettinger JA; Scheifele DW; Vaudry W; Halperin SA; Law BJ Vaccine; 2013 Nov; 31(48):5700-5. PubMed ID: 24099871 [TBL] [Abstract][Full Text] [Related]
7. Understanding the role of human variation in vaccine adverse events: the Clinical Immunization Safety Assessment Network. LaRussa PS; Edwards KM; Dekker CL; Klein NP; Halsey NA; Marchant C; Baxter R; Engler RJ; Kissner J; Slade BA Pediatrics; 2011 May; 127 Suppl 1():S65-73. PubMed ID: 21502239 [TBL] [Abstract][Full Text] [Related]
8. Surveillance for adverse events following immunization (AEFI) in Switzerland--1991-2001. Schumacher Z; Bourquin C; Heininger U Vaccine; 2010 May; 28(24):4059-64. PubMed ID: 20406662 [TBL] [Abstract][Full Text] [Related]
9. Safety monitoring in vaccine development and immunization. Lee CJ; Lee LH; Lu CH; Huang YJ; Chu ML Acta Paediatr Taiwan; 2006; 47(1):7-13. PubMed ID: 17016963 [TBL] [Abstract][Full Text] [Related]
10. The monitoring of adverse events following immunization. Tatley M N Z Med J; 2002 Nov; 115(1165):U247; author reply U247. PubMed ID: 12552289 [No Abstract] [Full Text] [Related]
11. [Surveillance system for adverse events following immunization against yellow fever in Burkina Faso in 2008. Good practice recommendations]. Yaméogo TM; Breugelmans JG; Kambou JL; Badolo O; Tiendrebéogo S; Traoré E; Avokey F; Yactayo S Med Trop (Mars); 2009 Aug; 69(4):320-1. PubMed ID: 19725376 [TBL] [Abstract][Full Text] [Related]
12. Safety reporting in developing country vaccine clinical trials-a systematic review. Muehlhans S; Richard G; Ali M; Codarini G; Elemuwa C; Khamesipour A; Maurer W; Mworozi E; Kochhar S; Rundblad G; Vuitton D; Rath B Vaccine; 2012 May; 30(22):3255-65. PubMed ID: 22406279 [TBL] [Abstract][Full Text] [Related]
13. Suggestions for improving the monitoring of adverse events following immunization in New Zealand. Miller M; Turner N N Z Med J; 2002 Sep; 115(1162):U186. PubMed ID: 12386665 [No Abstract] [Full Text] [Related]
14. Causality assessment of adverse events reported to the Vaccine Adverse Event Reporting System (VAERS). Loughlin AM; Marchant CD; Adams W; Barnett E; Baxter R; Black S; Casey C; Dekker C; Edwards KM; Klein J; Klein NP; LaRussa P; Sparks R; Jakob K Vaccine; 2012 Nov; 30(50):7253-9. PubMed ID: 23063829 [TBL] [Abstract][Full Text] [Related]
15. A comparative assessment of immunization records in the Defense Medical Surveillance System and the Vaccine Adverse Event Reporting System. McNeil MM; Ma G; Aranas A; Payne DC; Rose CE Vaccine; 2007 Apr; 25(17):3428-36. PubMed ID: 17258846 [TBL] [Abstract][Full Text] [Related]
16. Elective termination of pregnancy after vaccination reported to the Vaccine Adverse Event Reporting System (VAERS): 1990-2006. Chang S; Ball R; Braun MM Vaccine; 2008 May; 26(19):2428-32. PubMed ID: 18406499 [TBL] [Abstract][Full Text] [Related]
17. Surveillance of adverse events following immunisation: the model of SAEFVIC, Victoria. Clothier HJ; Crawford NW; Kempe A; Buttery JP Commun Dis Intell Q Rep; 2011 Dec; 35(4):294-8. PubMed ID: 22624490 [TBL] [Abstract][Full Text] [Related]
19. Reporting of adverse events following immunization in Australia. Isaacs D; Lawrence G; Boyd I; Ronaldson K; McEwen J J Paediatr Child Health; 2005 Apr; 41(4):163-6. PubMed ID: 15813867 [TBL] [Abstract][Full Text] [Related]
20. Developing a national system for dealing with adverse events following immunization. Mehta U; Milstien JB; Duclos P; Folb PI Bull World Health Organ; 2000; 78(2):170-7. PubMed ID: 10743281 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]